Healthways, Inc. (HWAY) Misses Q2 EPS by 1c

Healthways, Inc. (NASDAQ: HWAY) reported Q2 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $180.6 million versus the consensus estimate of $179.53 million.

Affirms Financial Guidance for 2014.

“Our financial results for the second quarter were consistent with our expectations,” commented Leedle. “We have now generated four consecutive quarters of sequential-quarter revenue growth. Our revenue growth of 9% for the first half of the year generated better margins, leading to a 16% increase in adjusted EBITDA.

“Our net cash flows from operations for the quarter were $10.2 million, while second-quarter capital expenditures were $10.4 million. Our ratio of total debt to EBITDA, as calculated under our credit agreement, improved to 3.9 at the end of the quarter from 4.2 at the end of the first quarter of 2014.”

For earnings history and earnings-related data on Healthways, Inc. (HWAY) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
• Federated Hermes (FHI) Reports In-Line Q1 EPS